1. MicroRNA‐383 is a tumor suppressor in human lung cancer by targeting endothelial PAS domain‐containing protein 1
    Hongjing Ma et al, 2016, Cell Biochemistry and Function CrossRef
  2. Feasibility of Unbiased RNA Profiling of Colorectal Tumors: A Proof of Principle
    Vardit Moshayoff et al, 2016, PLOS ONE CrossRef
  3. Metastasis-associated in colon cancer 1: A promising biomarker for the metastasis and prognosis of colorectal cancer
    He Li et al, 2017, Oncology Letters CrossRef
  4. Proliferating cell nuclear antigen clamp associated factor, a potential proto-oncogene with increased expression in malignant gastrointestinal tumors
    Li-Juan Liu et al, 2021, World Journal of Gastrointestinal Oncology CrossRef
  5. Integrative Bioinformatics Analysis Reveals New Prognostic Biomarkers of Clear Cell Renal Cell Carcinoma
    Henriett Butz et al, 2014, Clinical Chemistry CrossRef
  6. PDK4 promotes tumorigenesis and cisplatin resistance in lung adenocarcinoma via transcriptional regulation of EPAS1
    Shuo Yu et al, 2021, Cancer Chemotherapy and Pharmacology CrossRef
  7. Effective prediction of potential ferroptosis critical genes in clinical colorectal cancer
    Hongliang Huang et al, 2022, Frontiers in Oncology CrossRef
  8. Paf15 expression correlates with rectal cancer prognosis, cell proliferation and radiation response
    Rong Yan et al, 2016, Oncotarget CrossRef
  9. Identification of novel mutations and functional impacts of EPAS1 in colorectal cancer
    Farhadul Islam et al, 2021, Cancer Medicine CrossRef
  10. The role of circadian genes in the pathogenesis of colorectal cancer
    Saiedeh Razi Soofiyani et al, 2021, Gene CrossRef
  11. Distinct Patterns of Expression of Transcription Factors in Response to Interferonβ and Interferonλ1
    Hilary Novatt et al, 2016, Journal of Interferon & Cytokine Research CrossRef
  12. The E2 ubiquitin-conjugating enzyme UbcH5c: an emerging target in cancer and immune disorders
    Yuan Zhou et al, 2020, Drug Discovery Today CrossRef
  13. Prognostic Potential of DNA Methylation and Transcript Levels of HIF1A and EPAS1 in Colorectal Cancer
    Agnieszka Anna Rawłuszko-Wieczorek et al, 2014, Molecular Cancer Research CrossRef
  14. Circulating cell-free nucleic acids as biomarkers in colorectal cancer screening and diagnosis - an update
    Béla Molnár et al, 2019, Expert Review of Molecular Diagnostics CrossRef
  15. New Insights from Proteomic Analysis of Wnt Signaling
    Matthew P. Walker et al, 2014, Wnt Signaling in Development and Disease CrossRef
  16. Potential cancer-related role of circadian gene TIMELESS suggested by expression profiling and in vitro analyses
    Yingying Mao et al, 2013, BMC Cancer CrossRef
  17. Regulatory activity based risk model identifies survival of stage II and III colorectal carcinoma
    Gang Liu et al, 2017, Oncotarget CrossRef
  18. Molecular Deregulation of EPAS1 in the Pathogenesis of Esophageal Squamous Cell Carcinoma
    Farhadul Islam et al, 2020, Frontiers in Oncology CrossRef
  19. Prognostic Value and Clinicopathological Differences of HIFs in Colorectal Cancer: Evidence from Meta-Analysis
    Zhigang Chen et al, 2013, PLoS ONE CrossRef